Cancer Family
Genitourinary System Neoplasm
CI-CAN-00000018Explore in graph →
Non-malignant3,846 active trials61 approved drugs306 evidence items
- NCIt
- C156482
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000018Explore in graph →
Clinical trials
17,382 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01442519 | Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer(BCG/EMDA-MMC) | completed | Phase 3 | 212 | University of Rome Tor VergataOTHER | 1 | Sep 28, 2011 | clinicaltrials |
| NCT00925418 | Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer(CRYO1) | completed | Phase 3 | 168 | Institut Paoli-CalmettesOTHER |
| 1 |
| Sep 14, 2011 |
| clinicaltrials |
| NCT00478114 | Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC) | completed | Phase 3 | 15 | Mahidol UniversityOTHER | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00057720 | TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer | completed | Phase 3 | 440 | TelikINDUSTRY | 13 | Jul 25, 2011 | clinicaltrials |
| NCT00626431 | A Study of Leuprolide to Treat Prostate Cancer | completed | Phase 3 | 310 | AbbottINDUSTRY | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00782145 | A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families | completed | Phase 3 | 198 | Tufts Medical CenterOTHER | 1 | Jul 13, 2011 | clinicaltrials |
| NCT00270166 | The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | completed | Phase 3 | 201 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 18, 2011 | clinicaltrials |
| NCT01014026 | Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention(APACHE-1) | completed | Phase 3 | 734 | University Hospital, ToursOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00244309 | Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer | completed | Phase 3 | 348 | Case Comprehensive Cancer CenterOTHER | 1 | May 4, 2011 | clinicaltrials |
| NCT00964210 | Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination(HPV) | completed | Phase 3 | 240 | Murdoch Childrens Research InstituteOTHER | 1 | Apr 15, 2011 | clinicaltrials |
| NCT00417079 | XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer(TROPIC) | completed | Phase 3 | 755 | SanofiINDUSTRY | 26 | Mar 10, 2011 | clinicaltrials |
| NCT00191646 | An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy | completed | Phase 3 | 919 | Eli Lilly and CompanyINDUSTRY | 2 | Mar 4, 2011 | clinicaltrials |
| NCT00330707 | Combined Use of BCG and Interferon Alpha in Bladder Cancer | completed | Phase 2 / Phase 3 | 140 | National University Hospital, SingaporeOTHER | 1 | Mar 4, 2011 | clinicaltrials |
| NCT00003115 | Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy | completed | Phase 3 | 40 | Roswell Park Cancer InstituteOTHER | 1 | Feb 23, 2011 | clinicaltrials |
| NCT00046943 | Atrasentan in Treating Patients With Prostate Cancer | completed | Phase 3 | — | AbbottINDUSTRY | 1 | Feb 21, 2011 | clinicaltrials |
| NCT00233610 | Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer | completed | Phase 3 | 180 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00941252 | ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial(ITIC) | completed | Phase 2 / Phase 3 | 60 | Medical University of ViennaOTHER | 1 | Jan 24, 2011 | clinicaltrials |
| NCT00268892 | Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer | completed | Phase 2 / Phase 3 | 278 | Ferring PharmaceuticalsINDUSTRY | 10 | Dec 24, 2010 | clinicaltrials |
| NCT01258413 | Laparoscopic vs Abdominal Radical Hysterectomy In Patients With Early Cervical Cancer | completed | Phase 3 | 30 | Hospital Nossa Senhora da ConceicaoOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT00002881 | Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Nov 9, 2010 | clinicaltrials |
| NCT00005947 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 3 | 127 | DendreonINDUSTRY | 1 | Nov 1, 2010 | clinicaltrials |
| NCT00598312 | Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer | completed | Phase 3 | 201 | Oakwood Laboratories, LLCINDUSTRY | 1 | Sep 8, 2010 | clinicaltrials |
| NCT00065442 | Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy | completed | Phase 3 | 512 | DendreonINDUSTRY | 2 | Sep 6, 2010 | clinicaltrials |
| NCT00201916 | Shorter Radiation Schedule for the Treatment of Prostate Cancer | completed | Phase 3 | 936 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Aug 17, 2010 | clinicaltrials |
| NCT00152919 | Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy | completed | Phase 3 | 100 | University Health Network, TorontoOTHER | 1 | Aug 13, 2010 | clinicaltrials |
| NCT01086683 | Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course | completed | Phase 2 / Phase 3 | 513 | Danish Cancer SocietyOTHER | 1 | Mar 15, 2010 | clinicaltrials |
| NCT00048841 | Prevention of Osteoporosis in Men With Prostate Cancer | completed | Phase 3 | 112 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00083889 | SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma | completed | Phase 3 | 750 | PfizerINDUSTRY | 11 | Jan 26, 2010 | clinicaltrials |
| NCT00196807 | Prostate Cancer Screening: Fostering Informed Decisions | completed | Phase 3 | 543 | Georgetown UniversityOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00196781 | Treatment Decision Making in Early-Stage Prostate Cancer | completed | Phase 3 | 168 | Georgetown UniversityOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00315237 | Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract | completed | Phase 3 | 364 | Pierre Fabre MedicamentINDUSTRY | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00136487 | Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer | completed | Phase 2 / Phase 3 | 85 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00191100 | Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix | completed | Phase 3 | 515 | Eli Lilly and CompanyINDUSTRY | 7 | Aug 11, 2009 | clinicaltrials |
| NCT00712595 | Mifepristone for Treatment of Uterine Fibroids(Mifemyo) | completed | Phase 2 / Phase 3 | 200 | Mediterranea Medica S. L.OTHER | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00841113 | Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer | completed | Phase 3 | 177 | Speciality European Pharma LimitedINDUSTRY | 0 | Feb 11, 2009 | clinicaltrials |
| NCT00005966 | Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 4 | Feb 5, 2009 | clinicaltrials |
| NCT00156026 | Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1 | completed | Phase 3 | 415 | Ontario Clinical Oncology Group (OCOG)OTHER | 2 | Jan 29, 2009 | clinicaltrials |
| NCT00489060 | A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate Cancer | completed | Phase 3 | 244 | University of CalgaryOTHER | 1 | Jul 17, 2008 | clinicaltrials |
| NCT00692107 | Radiotherapy for Prostate Cancer: Conventional Dose Versus High Dose | completed | Phase 3 | 669 | The Netherlands Cancer InstituteOTHER | 1 | Jun 6, 2008 | clinicaltrials |
| NCT00152256 | A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids | completed | Phase 3 | 239 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00156208 | Safety of Treatment of Uterine Fibroids With Asoprisnil | completed | Phase 3 | 166 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00156156 | Study of Asoprisnil in the Treatment of Uterine Fibroids. | completed | Phase 3 | 149 | AbbottINDUSTRY | 0 | May 28, 2008 | clinicaltrials |
| NCT00076531 | Clinical Trial for Prostate Cancer | completed | Phase 3 | — | Oakwood Laboratories, LLCINDUSTRY | 0 | Jan 28, 2008 | clinicaltrials |
| NCT00127478 | A Long Term Safety Study With Atrasentan | completed | Phase 2 / Phase 3 | 166 | AbbottINDUSTRY | 5 | Nov 29, 2007 | clinicaltrials |
| NCT00128531 | Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer | completed | Phase 3 | 120 | GP-PharmINDUSTRY | 9 | Nov 14, 2007 | clinicaltrials |
| NCT00548600 | Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate | completed | Phase 3 | 112 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 24, 2007 | clinicaltrials |
| NCT00421694 | Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide | completed | Phase 2 / Phase 3 | 119 | University of L'AquilaOTHER | 1 | Oct 8, 2007 | clinicaltrials |
| NCT00036556 | Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 941 | AbbottINDUSTRY | 17 | Aug 15, 2007 | clinicaltrials |
| NCT00494546 | High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer | completed | Phase 3 | 568 | VA Puget Sound Health Care SystemFED | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00191607 | A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. | completed | Phase 3 | 162 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
Data updated 23 days agoSource updated Sep 28, 2011source: clinicaltrials